Non-vitamin K antagonist oral anticoagulants beneficial for patients with AF, cancer

non vitamin k antagonist oral anticoagulants beneficial for patients with af cancer

Sumary of Non-vitamin K antagonist oral anticoagulants beneficial for patients with AF, cancer:

  • July 22, 2021 2 min read Source/Disclosures Published by: Disclosures: Chan reports no relevant financial disclosures.
  • Back to Healio In patients with atrial fibrillation and cancer, non-vitamin K antagonist oral anticoagulants outperformed warfarin in thrombotic and bleeding endpoints, according to findings published in Stroke.
  • 120.033470. The nationwide, retrospective, population-based cohort study assessed the Taiwan National Health Insurance Research Database from June 2012 to December 2017. Researchers identified 6,274 patients (mean age, 77 years;
  • According to the researchers, the results of this study are important in clinical practice because this patient population is underrepresented in clinical trials, especially if presenting with active cancer.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close